UNSPSC 51293204: Phenelzine sulfate

This classification denotes a monoamine oxidase inhibitor with the molecular formula C8H12N2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2681D7P965, chemically known as hydrazine, phenethyl-, sulfate (1:1) but more generally known as phenelzine sulfate, which bears US NIH Compound Identifier 61100. European Medicines Agency schedules Phenelzine sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03740MIG.

Most nations, for tariff and trade purposes, schedule phenelzine sulfate under HS 29280090 and SITC 51486. As of Q4 2014, PHENELZINE SULFATE remains US FDA's Preferred Term for this commodity. Phenelzine sulfate bears US NLM identifiers UMLS ID C0701388 and NCI Concept Code C47668. SMILES: C1CCC(CC1)CCNN.OS(=O)(=O)O.

UNSPSC 51293204 Phenelzine sulfate is a Commodity code for a specific monoamine oxidase inhibitor antidepressant medication. However, the recent state and local procurement activity tagged under this code does not reflect purchases of phenelzine sulfate itself; instead, the opportunities show state and local governments procuring naloxone (an opioid antagonist), generic multi-source pharmaceuticals and over-the-counter products through cooperative channels, and exploring direct-to-manufacturer pharmacy benefit programs. The code's nominal scope and actual recent solicitation activity diverge significantly, suggesting either tagging misalignment in the source system or that phenelzine sulfate procurement operates outside the visible state and local contracting channels. The mix of issuing bodies includes county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), alongside their authorized pharmaceutical wholesalers.

Geographically, the recent activity spans Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County's competitive IFB (Solicitation IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries; the Texas HHS Commission's RFI (HHS0017013, posted April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager arrangements; and Minnesota's MMCAP cooperative RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers. The MMCAP procurement shows state and local demand for generic medications with detailed NDC and packaging specifications, cGMP and DSCSA compliance requirements, and fixed-fee contracting through established wholesale channels. If pursuing this code, verify that your product or service matches phenelzine sulfate specifically or clarify the correct UNSPSC classification, as the recent record shows little direct activity under the nominal commodity.